Data on features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and adolescents are scarce. We report preliminary results of an Italian multicentre study comprising 168 laboratory-confirmed paediatric cases (median: 2.3 years, range: 1 day–17.7 years, 55.9% males), of which 67.9% were hospitalised and 19.6% had comorbidities. Fever was the most common symptom, gastrointestinal manifestations were frequent; two children required intensive care, five had seizures, 49 received experimental treatments and all recovered.

Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020 / S. Garazzino, C. Montagnani, D. Dona, A. Meini, E. Felici, G. Vergine, S. Bernardi, R. Giacchero, A.L. Vecchio, P. Marchisio, G. Nicolini, L. Pierantoni, I. Rabbone, G. Banderali, M. Denina, E. Venturini, A. Krzysztofiak, R. Badolato, S. Bianchini, L. Galli, A. Villani, G. Castelli-Gattinara. - In: EUROSURVEILLANCE. - ISSN 1560-7917. - 25:18(2020 May 07), pp. 1-4. [10.2807/1560-7917.ES.2020.25.18.2000600]

Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020

P. Marchisio;
2020

Abstract

Data on features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in children and adolescents are scarce. We report preliminary results of an Italian multicentre study comprising 168 laboratory-confirmed paediatric cases (median: 2.3 years, range: 1 day–17.7 years, 55.9% males), of which 67.9% were hospitalised and 19.6% had comorbidities. Fever was the most common symptom, gastrointestinal manifestations were frequent; two children required intensive care, five had seizures, 49 received experimental treatments and all recovered.
SARS-CoV-2 infection; children; covid-19; hydroxychloroquine; pneumonia; Adolescent; Antiviral Agents; Betacoronavirus; Child; Child, Preschool; Chronic Disease; Clinical Laboratory Techniques; Coinfection; Comorbidity; Coronavirus; Coronavirus Infections; Diarrhea; Disease Outbreaks; Feces; Female; Fever; Hospitals, Pediatric; Humans; Immunocompromised Host; Infant; Infant, Newborn; Italy; Male; Noninvasive Ventilation; Pandemics; Pneumonia, Viral; Protease Inhibitors; Retrospective Studies; Severe Acute Respiratory Syndrome; Treatment Outcome
Settore MED/38 - Pediatria Generale e Specialistica
7-mag-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
GARAZZINO multicentre Italian study Eurosurveillance 2020.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 105.34 kB
Formato Adobe PDF
105.34 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/751466
Citazioni
  • ???jsp.display-item.citation.pmc??? 139
  • Scopus 203
  • ???jsp.display-item.citation.isi??? 202
social impact